Jessup 2019

By facebooker_1396303453840174
  • 250,000 BCE

    Emergence of the Kayleff Yak

  • 1000 BCE

    Emergence of the Pivzao civilization

  • 1400

    Zhenge He trading expedition (15th century)

    The first outside account of the Yak

  • Colonization of the Gaur Highlinds by the Kingdom of Jeramia

  • Jeramia granted independence to its colonies

    (including the State of Aurok and the Republic of Rakkab)

  • Establishment of DORTA

    (received between 3-5% of the annual budget from 1965 to 1996)

  • Privatization of DORTA

    Adoption of legislation by Rakkab's Parliament on company's privatization

  • Incorporation of DORTA M/S in Rakkab

  • Start of public trading of DORTA's shares on the NY Stock Exchange

  • Dr. Isaac Bello starts working in DORTA's pharmaceutical division and private hospital near the border with Aurok

  • Dr. Bello's hospital practice (1998-2000)

    Observed that the incidence of diabetes and obesity was lower among the Aurokan patients

  • Dr. Bello investigates Aurokan dietary and cultural practives in rural Aurok

  • Dr. Bello's article in the Lancet

    Summarization of his findings - referred to his discovery as "the Lustuk Enzyme"

  • Dr. Bello and biologists from DORTA isolated the Lustuk Enzyme

    They also produced an experimental medication on its basis and tested it, including on human subjects

  • DORTA filed a patent application for "Gallvectra" with the Rakkabi Intellectual Property Ministry

    Dr. Bello - inventor in the application

  • Cressida Cauty's article in Human Organization journal "The Lustuk Enzyme in the Aurokan Diet"

  • Tom Wynet, the Aurokan Minister of Intellectual Property, wrote to his Rakkabi counterpart

  • Pattern attorneys for DORTA reply to Minister Wynet's letter

  • The Rakkabi Ministry published order granting the patent

    +both letter and all other correspondence pertaining to the patent application in its Official Journal

  • DORTA proceeds to pursue IP property for Gallvectra in all of the countries in which it has subsidiaries

  • DORTA begins marketing Gallvectra in countries that had approved for its prescription use

    As of 2018 - Gallvectra has been approved for use and sale by DORTA in more than 85 countries

  • Meeting of DORTA shareholders

    Carla Alexander, the Chief Executive Officer of DORTA reports that 2014 worldwide sales topped 2 billion euro

  • Winter 2016-2017

    Private hunters paid by DORTA kill approximately 30,000 Yak.
    A subsequent survey by YLSA scientists conclude that "the Yak population is down nearly 10 % from 2 years ago"

  • Publishment of an unsigned editorial "What Will Happen When the Yak Do Not Return" in Aurok Truth

  • Courier-Mail (Brisbane-based) published an investigative report "Gallvectra Saves Lives: But Where Are all the Yak Gallbladders Coming From?"

    It says:
    -since 2011 DORTA had been offering a substantial cash rewars for Yak gallbladders through ads in hunting enthusiast magazines
    -the number of Yak license applications increased to more than 300 per year from 2011
    -From Oct 2015 to Febr 2016 hunters killed nearly 30,000 Yak

  • Aurokan Parliament enacts a bill to fund Yak research and inroduces a 5-year moratorium on the hunting of female Yak of breeding age

  • Meeting of the leaders of the Aurokan Parliament with DORTA researchers

  • Gallvectra was added to the WHO Model List of Essential Medicines at the 20th Expert Committee on the Selection and Use of Essential Medicines

  • YLSA report

    followed by Prime Minister Sumun statement depicting the DORTA Yak harvest as "a danger to Aurokan culture" and calling on Rakkab "to act in accordance with its int'l obligations"
    +YLSA reported in a nationwide survey that townspeople were seeing herds sizes smaller than in 2010

  • Aurokan villagers demonstrations

    By the time of its June 2017 annual shareholder meeting, DORTA reported gross sales of Gallvectra of more than 3.2 euro billion worldwide

  • Aurokan national holiday marking the departure of the Yak for the sourt and demonstration outside the PM's office in Transcentral

  • PM Sumun visits Rakkab to discuss the issue of the Yak with Rakkabi PM Derlap Frangie and DORTA CEO Ms. Alexander

  • DORTA's annual shareholder meeting

    (Sept and Oct of 2016 - Yak returns to their winter grounds in Rakkab)
    Attendee asks where the company is concerned about the sustainability of the herd

  • Rakkabi Minstry of Agriculture releases on all major digital platforms an app "YakTrakker"

  • YLSA's press release - YakTrakker is used by hunters to follow and hunt the herds

    (2 weeks later after the release of YakTrakker)

  • Gallvectra is added to the WHO Model List of Essential Medicines

    20th Expert Committee on the Selection and Use of Essential Medicines

  • Aurokan villagers demonstrations and adoption of the Yak Protection Act by the Aurokan's Parliament

    By the time of DORTA's June 2017 annual shareholder meeting, it reported gross sales of Gallvectra of more than 3.2 euro billion worldwide

  • Yak Protection Act enters into force

    +Aurok Ministry of Foreign Affairs sents a notification to the Secretariat of the CITES, requesting the Kayleff Yak be included in Appendix III of CITES

  • PM Sumun addresses UN GA

  • Yak is included in Appendix III of CITES

  • PM Sumun and Frangie meet in Transcentral

  • Yak is included in Appendix I of the CMS

    At the 12th Meeting of the Conference of Parties to the Convention on Migratory Species
    +objection from the delegate from Rakkab

  • Rakkabi Ministry of Agriculture promulgates Regulation AG/2017-0300 on new licensing policy on Kayleff Yaks

  • DORTA applied to the Rakkabi Ministry of Agriculture for a license

  • DORTA is granted a license for the hunting of the Kayleff Yak

  • DORTA publicly announces offers for payment for Yak gallbladders, only to registered agents of the company

  • 200 Rakkabis signs 1-year contracts

    YLSA annual survey - 28,500 were killed by DORTA agents during Jan and Febr of that year

  • Joint notification to the ICJ

  • 18th Conference of the Parties to CITES

  • YLSA's 25th anniversary of its founding